Goldman Sachs Group »

Iovance Biotherapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $30M 3.7M 8.13
2023-09-30 $17M 3.8M 4.55
2023-06-30 $25M 3.5M 7.04
2023-03-31 $24M 3.9M 6.11
2022-12-31 $23M 3.6M 6.39
2022-06-30 $22M 2.0M 11.04
2022-03-31 $10M 599k 16.65
2021-12-31 $29M 1.5M 19.09
2021-09-30 $31M 1.3M 24.66
2021-03-31 $61M 1.9M 31.66
2020-12-31 $35M 746k 46.40
2020-09-30 $27M 819k 32.92
2020-06-30 $39M 1.4M 27.45
2019-12-31 $34M 1.2M 27.68
2019-09-30 $19M 1.0M 18.20
2019-06-30 $14M 573k 24.52
2019-03-31 $4.2M 437k 9.51
2018-12-31 $6.1M 693k 8.86
2018-09-30 $2.2M 193k 11.25
2018-06-30 $1.1M 85k 12.79
2018-03-31 $1.6M 95k 16.90
2017-12-31 $507k 63k 8.00
2017-09-30 $1.7M 223k 7.75
2017-06-30 $1.6M 214k 7.35